Article Details
Retrieved on: 2021-05-05 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Still, a labeling snafu has landed the company's injectables subsidiary back on the FDA's recall list. Pfizer's Hospira is recalling one lot each of the ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here